Literature DB >> 23721075

Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance.

QiXing Chen1, Kai Zhang, Yue Jin, Tao Zhu, Baoli Cheng, Qiang Shu, XiangMing Fang.   

Abstract

RATIONALE: Triggering receptor expressed on myeloid cells-2 (TREM-2) is a cell surface receptor primarily expressed on macrophages and monocyte-derived cells. TREM-2 not only functions as a regulator of inflammatory response, but also serves as a phagocytic receptor for bacteria. However, the role of TREM-2 in sepsis remains unknown.
OBJECTIVES: To investigate whether TREM-2 plays a role in sepsis.
METHODS: The manner of expression of TREM-2 was evaluated in patients with sepsis and in polymicrobial septic mouse model induced by the cecum ligation and puncture approach. Recombinant mouse TREM-2 was used to block the effect of TREM-2. Bone marrow-derived myeloid cells (BMMCs) that overexpress TREM-2 were administrated into septic mice at various times after cecum ligation and puncture.
MEASUREMENTS AND MAIN RESULTS: The expression levels of TREM-2 were up-regulated in patients with sepsis and septic mice. The kinetics of TREM-2 expression in polymicrobial sepsis was comparable with that of bacteria burden in peritoneal lavage fluid. Blocking the effect of TREM-2 resulted in markedly increased mortality and bacterial burden in polymicrobial sepsis. Administration of TREM-2-overexpressing BMMCs significantly reduced the mortality, even when it was administered 4 hours after the initiation of sepsis. However, injection of TREM-2-overexpressing BMMCs into LPS-challenged endotoxemia mice did not improve the survival rate. The protective effect of TREM-2 in polymicrobial sepsis was not associated with its antiinflammatory properties, but it enhanced bacterial clearance in vivo. Furthermore, administration of TREM-2-overexpressing BMMCs improved the organ injury.
CONCLUSIONS: TREM-2 plays an important role in the host defense response to sepsis by enhancing bacterial clearance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23721075     DOI: 10.1164/rccm.201211-1967OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  31 in total

Review 1.  Triggering receptor expressed on myeloid cells receptor family modulators: a patent review.

Authors:  Christopher J Pelham; Amit N Pandya; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2014-11-01       Impact factor: 6.674

2.  Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2.

Authors:  Athena Sudom; Santosh Talreja; Jean Danao; Eric Bragg; Rob Kegel; Xiaoshan Min; Jason Richardson; Zhongqi Zhang; Nikolai Sharkov; Edoardo Marcora; Steve Thibault; Jodi Bradley; Steve Wood; Ai-Ching Lim; Hang Chen; Songli Wang; Ian N Foltz; Shilpa Sambashivan; Zhulun Wang
Journal:  J Biol Chem       Date:  2018-05-24       Impact factor: 5.157

3.  TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor.

Authors:  Skylar J Ferrara; Priya Chaudhary; Margaret J DeBell; Gail Marracci; Hannah Miller; Evan Calkins; Edvinas Pocius; Brooke A Napier; Ben Emery; Dennis Bourdette; Thomas S Scanlan
Journal:  Cell Chem Biol       Date:  2021-08-09       Impact factor: 8.116

4.  Triggering receptor expressed on myeloid cells-2 promotes survival of cardiomyocytes after myocardial ischemic injury through PI3K/AKT pathway.

Authors:  Cong Fu; Qiancheng Xu; Jichun Liu; Shengxing Tang; Can Liu; Yuhan Cao
Journal:  Cardiovasc Diagn Ther       Date:  2022-02

5.  TREM2 governs Kupffer cell activation and explains belr1 genetic resistance to malaria liver stage infection.

Authors:  Lígia Antunes Gonçalves; Lurdes Rodrigues-Duarte; Joana Rodo; Luciana Vieira de Moraes; Isabel Marques; Carlos Penha-Gonçalves
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 6.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

7.  Impact of TREM-2 gene silencing on inflammatory response of endotoxin-induced acute lung injury in mice.

Authors:  Dai Liu; Yanting Dong; Zhuola Liu; Bo Niu; Yaowei Wang; Xiaoling Gao
Journal:  Mol Cell Biochem       Date:  2014-06-11       Impact factor: 3.396

Review 8.  Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis.

Authors:  Gan Luo; Jue Zhang; Yaqi Sun; Ya Wang; Hanbin Wang; Baoli Cheng; Qiang Shu; Xiangming Fang
Journal:  Nanomicro Lett       Date:  2021-03-08

9.  TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis.

Authors:  Jinchao Hou; Jue Zhang; Ping Cui; Yingyue Zhou; Can Liu; Xiaoliang Wu; Yun Ji; Sicong Wang; Baoli Cheng; Hui Ye; Liqi Shu; Kai Zhang; Di Wang; Jielin Xu; Qiang Shu; Marco Colonna; Xiangming Fang
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

10.  Triggering receptor expressed on myeloid cells-2 fine-tunes inflammatory responses in murine Gram-negative sepsis.

Authors:  Riem Gawish; Rui Martins; Benedikta Böhm; Terje Wimberger; Omar Sharif; Karin Lakovits; Mariane Schmidt; Sylvia Knapp
Journal:  FASEB J       Date:  2014-12-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.